Furthermore, as a matter of fact, previous studies paid much more attention to the roles of PRGs in solid carcinomas [e.g., hepatocellular carcinoma (Deng et al., 2022), breast cancer (Xu D. et al., 2021), lung adenocarcinoma (Lin W. et al., 2021), and colon adenocarcinoma (Luo et al., 2021)] with few studies, however, focusing on non-solid tumor such as AML. This evidence concerns the gene GART and hepatocellular carcinoma.